Replies to post #9529 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

I would suggest that the FDA will not repeat the kinds of disclosures it made in the Lovenox case in light of the Court’s ruling today.

[io_io]

Separately - about 15 years ago I wrote an detailed paper on patent law.

Clark, in light of your claimed expertise in patent law, I find it odd that you have been strangely silent on the most basic fundamentals:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77841890
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77982169